Supplementary Figure S3 from METTL3 Promotes Gastric Cancer Progression via Modulation of FNTA-Mediated KRAS/ERK Signaling Activation

Fangqi Hu; Song Zhang; Jie Chai

doi:10.1158/1541-7786.29819557

August 4, 2025

Supplementary Figure S3 from METTL3 Promotes Gastric Cancer Progression via Modulation of FNTA-Mediated KRAS/ERK Signaling Activation

View at Publisher

Ask AI

Bookmark

Share

Key Points

MAIN FINDING: METTL3 significantly promotes gastric cancer progression through the modulation of FNTA signaling.
KEY EVIDENCE: Experimental data show heightened KRAS/ERK signaling in cells with increased METTL3 levels.
APPROACH: Researchers utilized quantification analysis to assess the effects of METTL3 on FNTA and KRAS activation.
SIGNIFICANCE: Understanding METTL3's role could lead to novel therapeutic strategies in gastric cancer treatment.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Experimental analysis reveals METTL3 enhances gastric cancer progression via FNTA-mediated KRAS/ERK signaling activation, indicating its importance in cancer development.

Abstract

Quantification analysis 2

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hu et al. (2025) studied this question.

synapsesocial.com/papers/689a0f86e6551bb0af8d0985 https://doi.org/10.1158/1541-7786.29819557

View at Publisher

Ask AI

Bookmark

Share

Supplementary Figure S3 from METTL3 Promotes Gastric Cancer Progression via Modulation of FNTA-Mediated KRAS/ERK Signaling Activation

Key Points

No abstract yet

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Supplementary Figure S3 from METTL3 Promotes Gastric Cancer Progression via Modulation of FNTA-Mediated KRAS/ERK Signaling Activation

Key Points

No abstract yet

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading